EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Triplication of the PCDH19 Gene as a Novel Disease Mechanism Leading to Epileptic Encephalopathy Resembling Loss-of-Function Pathogenic Variants

Alba Gabaldón-Albero iD, Patricia Smeyers, Sara Hernández-Muela, Mónica Roselló iD, Carmen Orellana iD, Sandra Monfort, Silvestre Oltra, Francisco Martínez

Genes · 2024

DOI: 10.3390/genes15101312 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Genes, 2024. Verfasst von Alba Gabaldón-Albero und 7 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Group in Genetics, La Fe Health Research Institute, 46026 Valencia, Spain. Hauptthemen laut MEDLINE: Cadherins, Protocadherins. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Developmental and epileptic encephalopathy 9 (DEE9) (MIM #300088) affects heterozygous females and males with somatic pathogenic variants, while male carriers with hemizygous PCDH19 pathogenic variants are clinically unaffected. There are hundreds of pathogenic single nucleotide variants in the PCDH19 gene reported in the literature, which lead to the loss of function of the PCDH19 protein. To date, no phenotypes associated with overexpression or copy number gains have been described in this gene. Methods and results: We present a female patient with a de novo triplication in the Xq21.3–q22.1 chromosomal region, which includes the PCDH19 gene, which implies an unbalanced dose gain. This patient displayed a phenotype of epileptic encephalopathy compatible with DEE9. By comparison, another male patient with a similar duplication showed mild developmental delay and autism but never developed epilepsy. Conclusions: Here, we propose the dose gain of PCDH19 as a new pathogenic mechanism that results in a phenotype similar to that found in patients with loss-of-function variants in PCDH19, when present in a heterozygous state.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CadherinsProtocadherinsFemaleHumansMaleEpilepsyHeterozygoteLoss of Function MutationPhenotype

Stichwörter der Autor:innen

PCDH19 clustering epilepsyearly-onset epilepsygain-of-dosage genetic variantuniparental isodisomy

Substanzen

CadherinsPCDH19 protein, humanProtocadherins

Autor:innen und Institutionen

  • Translational Research Group in Genetics, La Fe Health Research Institute, 46026 Valencia, Spain.
  • Pediatric Neurology Section, Hospital Universitario y Politecnico La Fe, 46026 Valencia, Spain.
  • Genetics Unit, Hospital Universitario y Politecnico La Fe, 46026 Valencia, Spain.

ORCID-Profile: Alba Gabaldón-Albero, Mónica Roselló, Carmen Orellana

Förderung

  • Instituto de Salud Carlos III
  • European Union

Zitieren

APA

Gabaldón-Albero, A., Smeyers, P., Hernández-Muela, S., Roselló, M., Orellana, C., Monfort, S., Oltra, S., & Martínez, F. (2024). Triplication of the PCDH19 Gene as a Novel Disease Mechanism Leading to Epileptic Encephalopathy Resembling Loss-of-Function Pathogenic Variants. Genes. https://doi.org/10.3390/genes15101312

Vancouver

Gabaldón-Albero A, Smeyers P, Hernández-Muela S, Roselló M, Orellana C, Monfort S, et al. Triplication of the PCDH19 Gene as a Novel Disease Mechanism Leading to Epileptic Encephalopathy Resembling Loss-of-Function Pathogenic Variants. Genes. 2024. doi:10.3390/genes15101312

BibTeX
@article{GabaldnAlbero2024,
  author = {Gabaldón-Albero, Alba and Smeyers, Patricia and Hernández-Muela, Sara and Roselló, Mónica and Orellana, Carmen and Monfort, Sandra and Oltra, Silvestre and Martínez, Francisco},
  title = {Triplication of the PCDH19 Gene as a Novel Disease Mechanism Leading to Epileptic Encephalopathy Resembling Loss-of-Function Pathogenic Variants},
  journal = {Genes},
  year = {2024},
  doi = {10.3390/genes15101312}
}
Kostenlos starten →